New Guangzhou Nansha preferential tax incentive

Market prospects and investment paths Biopharma, short for biopharmaceuticals, are medical products produced using biotechnology (or biotech). Typical biopharma products include pharmaceuticals generated from living organisms, vaccines and gene therapy, among others. China’s biopharma industry has much attention home and abroad, especially after Chinese companies…

Invisible market access barriers when doing business in China

Market access barriers in the burgeoning market of Southwest China

An active investor’s perspective

Why businesses in China need to prepare for changes in regulation, buyer behaviour and the digital landscape

Interview with Adam Dunnett, secretary general, European Union Chamber of Commerce in China[1]

Asian private equity industry outlook favourable thanks to ongoing digitalisation trend

Investment opportunities for foreign-owned companies

China’s new security review measures for speculation in ‘sensitive’ areas